Season two begins with a summary of recent news in psychedelics, including developments in decriminalization efforts by several states, an update on Oregon’s measure 109 and psilocybin services, and the recent dissolving of Mindcure and what that means for big money players in the psychedelic space. Nate and Brian also speculate on various potential models of psychedelic-assisted therapy and the potential future of novel psychedelic substances currently being researched.
